<?xml version="1.0" ?>
<rss version="2.0">
<channel>
<title>CLINICAL RESEARCH &amp; DIAGNOSTICS CNS Diseases news from GEN</title><description>Reports on breakthroughs in CNS diseases.</description>
<lastBuildDate>Friday, November 20, 2009</lastBuildDate><link>http://www.genengnews.com/news/newslist.aspx?taxid=34</link>
<item>
<title>MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug"</title>
<description></description>
<pubDate>Thursday, November 19, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=68941954</link>
</item>
<item>
<title>AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing</title>
<description></description>
<pubDate>Thursday, November 19, 2009</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=68921983</link>
</item>
</channel>
</rss>
